BindingDB logo
myBDB logout

null

SMILES: CCC(=O)N[C@H]1CC[C@H](CC1)n1c2nc(Nc3ccc(cc3OC)N3CCN(C)CC3)ncc2c(cc1=O)C1CC1

InChI Key:

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50569986   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Dual specificity protein kinase TTK


(Homo sapiens (Human))
BDBM50569986
PNG
(CHEMBL4853433)
Show SMILES CCC(=O)N[C@H]1CC[C@H](CC1)n1c2nc(Nc3ccc(cc3OC)N3CCN(C)CC3)ncc2c(cc1=O)C1CC1 |r,wU:8.11,5.4,(31.93,-16.84,;31.94,-18.38,;30.61,-19.15,;30.62,-20.69,;29.27,-18.4,;29.26,-16.86,;27.92,-16.09,;27.91,-14.55,;29.24,-13.78,;30.58,-14.53,;30.59,-16.07,;29.23,-12.24,;27.89,-11.47,;26.56,-12.25,;25.23,-11.49,;23.9,-12.26,;22.56,-11.51,;22.55,-9.97,;21.21,-9.2,;19.88,-9.99,;19.89,-11.53,;21.23,-12.28,;21.24,-13.82,;19.91,-14.61,;18.54,-9.22,;17.21,-10,;15.87,-9.24,;15.86,-7.7,;14.53,-6.93,;17.19,-6.92,;18.53,-7.68,;25.21,-9.95,;26.55,-9.17,;27.88,-9.93,;29.21,-9.16,;30.55,-9.91,;30.56,-11.45,;31.9,-12.22,;29.21,-7.61,;28.42,-6.28,;29.96,-6.27,)|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 50n/an/an/an/an/an/a


TBA

Assay Description
Inhibition of recombinant full-length human TTK using MBP as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting b...


Citation and Details

Article DOI: 10.1016/j.ejmech.2020.113023
BindingDB Entry DOI: 10.7270/Q2GM8C33
More data for this
Ligand-Target Pair
Dual specificity protein kinase TTK


(Homo sapiens (Human))
BDBM50569986
PNG
(CHEMBL4853433)
Show SMILES CCC(=O)N[C@H]1CC[C@H](CC1)n1c2nc(Nc3ccc(cc3OC)N3CCN(C)CC3)ncc2c(cc1=O)C1CC1 |r,wU:8.11,5.4,(31.93,-16.84,;31.94,-18.38,;30.61,-19.15,;30.62,-20.69,;29.27,-18.4,;29.26,-16.86,;27.92,-16.09,;27.91,-14.55,;29.24,-13.78,;30.58,-14.53,;30.59,-16.07,;29.23,-12.24,;27.89,-11.47,;26.56,-12.25,;25.23,-11.49,;23.9,-12.26,;22.56,-11.51,;22.55,-9.97,;21.21,-9.2,;19.88,-9.99,;19.89,-11.53,;21.23,-12.28,;21.24,-13.82,;19.91,-14.61,;18.54,-9.22,;17.21,-10,;15.87,-9.24,;15.86,-7.7,;14.53,-6.93,;17.19,-6.92,;18.53,-7.68,;25.21,-9.95,;26.55,-9.17,;27.88,-9.93,;29.21,-9.16,;30.55,-9.91,;30.56,-11.45,;31.9,-12.22,;29.21,-7.61,;28.42,-6.28,;29.96,-6.27,)|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
Article
PubMed
n/an/an/a 7.90n/an/an/an/an/a


TBA

Assay Description
Binding affinity to wild-type human partial length TTK (N505 to V798 residues) expressed in bacterial expression system by active site-directed compe...


Citation and Details

Article DOI: 10.1016/j.ejmech.2020.113023
BindingDB Entry DOI: 10.7270/Q2GM8C33
More data for this
Ligand-Target Pair